Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aflibercept plus FOLFIRI vs placebo plus FOLFIRI in metastatic colorectal cancer
CTR20130302Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2014
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of aflibercept in metastatic colorectal adenocarcinoma (mCRC), sponsored by Sanofi. Started Jun 2014; status: completed.
02
Drugs
aflibercept
03
Conditions
metastatic colorectal adenocarcinoma (mCRC)
Beyond the preview
Go deeper on CTR20130302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130302.